文献速递糖尿病

β细胞质量对1型糖尿病患者血糖控制的重要性

Importance of beta cell mass for glycaemic control in people with type 1 diabetes.
PubMed 文献 · Diabetologia · 2022-11-17

本研究采用放射性标记外泌肽PET成像比较低血糖变异性(LGV)与高血糖变异性(HGV)1型糖尿病患者的β细胞质量。LGV组胰腺SUVmean高于HGV组(5.1 vs 2.9,p=0.008),且SUVmean与TIR及AUCC肽:AUC葡萄糖比值相关。结论认为LGV患者β细胞质量高于HGV患者,独立于β细胞功能。

要点

  • LGV组胰腺SUVmean为5.1,高于HGV组的2.9(p=0.008)。
  • SUVmean与TIR相关(r=0.64,p=0.01),与组织间葡萄糖SD相关(r=-0.66,p=0.007)。
  • AUCC肽:AUC葡萄糖比值LGV组数值上高于HGV组,但未达统计学显著(p=0.21)。

核心结论

  • 1型糖尿病LGV患者β细胞质量高于HGV患者,独立于β细胞功能。

研究设计与样本

  • 研究纳入LGV组9例和HGV组7例1型糖尿病患者,行混合餐耐受试验评估β细胞功能,佩戴盲法持续葡萄糖监测一周,静脉注射[68Ga]Ga-NODAGA-exendin-4后行PET成像定量胰腺摄取。

主要发现

  • LGV组HbA1c为46.0 mmol/mol(44.5-52.5)[6.4%(6.3-7)],低于HGV组的80 mmol/mol(69.0-110)[9.5%(8.5-12.2)],p=0.001。
  • LGV组TIR为75.6%(73.5-90.3),高于HGV组的38.7%(25.1-48.5),p=0.002。
  • LGV组胰腺SUVmean为5.1(3.6-5.6),高于HGV组的2.9(2.1-3.4),p=0.008。
  • AUCC肽:AUC葡萄糖比值LGV组为2.7×10⁻²(6.2×10⁻⁴-5.3×10⁻²),HGV组为9.3×10⁻⁴(4.7×10⁻⁴-5.2×10⁻³),p=0.21,未达统计学显著。
  • SUVmean与AUCC肽:AUC葡萄糖比值相关(Pearson r=0.64,p=0.01),与TIR相关(r=0.64,p=0.01),与组织间葡萄糖水平SD相关(r=-0.66,p=0.007)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The role of beta cell mass in the balance of glucose control and hypoglycaemic burden in people with type 1 diabetes is unclear. We applied positron emission tomography (PET) imaging with radiolabelled exendin to compare beta cell mass among people with type 1 diabetes and either low glucose variability (LGV) or high glucose variability (HGV). METHODS: All participants with either LGV (n=9) or HGV (n=7) underwent a mixed-meal tolerance test to determine beta cell function and wore a blinded continuous glucose monitor for a week. After an i.v. injection with [68Ga]Ga-NODAGA-exendin-4, PET images were acquired for the quantification of pancreatic uptake of radiolabelled exendin. The mean standardised uptake value (SUVmean) of the pancreas was used to determine the amount of beta cell mass. RESULTS: Participants with LGV had lower HbA1c (46.0 mmol/mol [44.5-52.5] [6.4% (6.3-7)] vs 80 mmol/mol [69.0-110] [9.5% (8.5-12.2)], p=0.001) and higher time in range (TIR) (75.6% [73.5-90.3] vs 38.7% [25.1-48.5], p=0.002) than those with HGV. The SUVmean of the pancreas was higher for the LGV than for the HGV group (5.1 [3.6-5.6] vs 2.9 [2.1-3.4], p=0.008). The AUCC-peptide:AUCglucose ratio was numerically, but not statistically, higher in the LGV compared with the HGV group (2.7×10-2 [6.2×10-4-5.3×10-2] vs 9.3×10-4 [4.7×10-4-5.2×10-3], p=0.21). SUVmean correlated with the AUCC-peptide:AUCglucose ratio (Pearson r=0.64, p=0.01), as well as with the TIR (r=0.64, p=0.01) and the SD of interstitial glucose levels (r=-0.66, p=0.007). CONCLUSION/INTERPRETATION: Our data show higher beta cell mass in people with type 1 diabetes and LGV than in those with HGV, independent of beta cell function.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Jansen TJP, Brom M, Boss M, et al. Importance of beta cell mass for glycaemic control in people with type 1 diabetes. Diabetologia. 2022. PMID: 36394644. doi:10.1007/s00125-022-05830-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。